Seminar

ACT Legislative Conference

FDA has announced a plan to issue some of its compounding guidance documents "for immediate implementation" — without any comment period from the industry.

This looming threat to participatory governance makes it imperative for industry professionals to mobilize and make their dissent heard. By attending ACT, you have an opportunity to confront this concerning issue head-on with legislators. It's a pivotal moment to amplify our voices, as these policy shifts can significantly impact our industry.

Please make it your priority to join us this May.

Related events

Related Insights